1. Home
  2. |Insights
  3. |COVID-19 and the False Claims Act

COVID-19 and the False Claims Act

Webinar | 04.07.21, 7:00 AM EDT - 8:30 AM EDT

Register

Please Join Crowell & Moring for a Webinar on COVID-19 and the False Claims Act: What to Expect and How to Defend Investigations, Audits, and Qui Tam Actions in a Post-Pandemic World.


The Pandemic has created new and expanded avenues of recovery for the government and whistleblowers under the False Claims Act. The massive influx of federal pandemic relief funds to small businesses, healthcare providers and other organizations; modifications to government contracts to address paid and sick leave as allowable costs; the dramatic increase in remote healthcare; and the vulnerabilities of elderly populations living in assisted living facilities or nursing homes in the U.S. generate additional bases for investigations and civil and criminal enforcement actions against companies faced with new and shifting compliance requirements in the post-Pandemic world.


On April 7, our panel will discuss what to expect and how to prepare for and defend investigations, audits, and qui tam actions as U.S. companies navigate Pandemic-related changes to business operations, including:


  • Provider Relief Funds & Paycheck Protection Program (“PPP”) Borrower Fraud
  • PPP Lender Fraud
  • Section 3610 Allowances
  • Telemedicine Kickback Schemes
  • Elder Abuse

We hope you can join us for this webinar discussion.


For more information, please visit these areas: Government Contracts

Contact

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights